MoonLake Immunotherapeutics's total assets for Q4 2025 were $424.43M, an increase of 2.44% from the previous quarter. MLTX total liabilities were $119.95M for the fiscal quarter, a -2.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.